Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Yumi Nishiya"'
Autor:
Daigo Asano, Koichi Nakamura, Yumi Nishiya, Hideyuki Shiozawa, Hideo Takakusa, Takahiro Shibayama, Shin-ichi Inoue, Tsuyoshi Shinozuka, Takakazu Hamada, Chizuko Yahara, Nobuaki Watanabe, Kouichi Yoshinari
Publikováno v:
Drug Metabolism and Disposition. 51:67-80
Autor:
Tomoyo Honda, Wataru Obuchi, Yumi Nishiya, Takahiro Shibayama, Kengo Watanabe, Nobuaki Watanabe
Publikováno v:
Biopharmaceutics & Drug Disposition. 43:213-217
The estimation of the contributions of UDP-glucuronosyl transferase (UGT) isoforms to the overall metabolism still suffers from technical difficulties due to limited information on enzyme levels in recombinant systems and specific inhibitors, unlike
Autor:
Issay Kitabayashi, Koichi Ichimura, Hideyuki Saya, Oltea Sampetrean, Makoto Suzuki, Daichi Baba, Tomoki Imaoka, Kanae Suzuki, Koichi Nakamura, Yumi Nishiya, Takahiko Seki, Masato Itoh, Ayuna Hattori, Takuo Katsumoto, Kazutsune Yamagata, Yutaka Shima, Yoko Ogawara, Masayuki Yamaguchi, Hironori Matsunaga, Makoto Nakagawa, Yukino Machida
Table S4 shows mean Kp, brain and Kp, cerebrum values of DS-1001a in mice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b263fdcb606667bbf6c8f561308c3ca
https://doi.org/10.1158/1535-7163.22509496.v1
https://doi.org/10.1158/1535-7163.22509496.v1
Autor:
Toshinori Agatsuma, Yuki Abe, Takashi Nakada, Ichiro Hayakawa, Tetsuo Aida, Tomoko Shibutani, Yumi Nishiya, Akiko Watanabe, Kazuyoshi Kumagai, Chiharu Hattori, Takanori Maejima, Jun Hasegawa, Michiko Yamato
Supplementary Data from DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2555c866d4671115aaf3d352455d62eb
https://doi.org/10.1158/1535-7163.22521898.v1
https://doi.org/10.1158/1535-7163.22521898.v1
Autor:
Issay Kitabayashi, Koichi Ichimura, Hideyuki Saya, Oltea Sampetrean, Makoto Suzuki, Daichi Baba, Tomoki Imaoka, Kanae Suzuki, Koichi Nakamura, Yumi Nishiya, Takahiko Seki, Masato Itoh, Ayuna Hattori, Takuo Katsumoto, Kazutsune Yamagata, Yutaka Shima, Yoko Ogawara, Masayuki Yamaguchi, Hironori Matsunaga, Makoto Nakagawa, Yukino Machida
Pyrograms for glioblastoma cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2133978dd4851759dae1c3d800a5ce57
https://doi.org/10.1158/1535-7163.22509520
https://doi.org/10.1158/1535-7163.22509520
Autor:
Issay Kitabayashi, Koichi Ichimura, Hideyuki Saya, Oltea Sampetrean, Makoto Suzuki, Daichi Baba, Tomoki Imaoka, Kanae Suzuki, Koichi Nakamura, Yumi Nishiya, Takahiko Seki, Masato Itoh, Ayuna Hattori, Takuo Katsumoto, Kazutsune Yamagata, Yutaka Shima, Yoko Ogawara, Masayuki Yamaguchi, Hironori Matsunaga, Makoto Nakagawa, Yukino Machida
Supplementary Data shows Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490b75cf5bb4a13fb489d1466c83487d
https://doi.org/10.1158/1535-7163.22509508
https://doi.org/10.1158/1535-7163.22509508
Autor:
Toshinori Agatsuma, Yuki Abe, Takashi Nakada, Ichiro Hayakawa, Tetsuo Aida, Tomoko Shibutani, Yumi Nishiya, Akiko Watanabe, Kazuyoshi Kumagai, Chiharu Hattori, Takanori Maejima, Jun Hasegawa, Michiko Yamato
B7-H3 is overexpressed in various solid tumors and has been considered as an attractive target for cancer therapy. Here, we report the development of DS-7300a, a novel B7-H3–targeting antibody–drug conjugate with a potent DNA topoisomerase I inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a31bd9f9c43f7e981e6be14ca30c4b1
https://doi.org/10.1158/1535-7163.c.6543217
https://doi.org/10.1158/1535-7163.c.6543217
Autor:
Issay Kitabayashi, Koichi Ichimura, Hideyuki Saya, Oltea Sampetrean, Makoto Suzuki, Daichi Baba, Tomoki Imaoka, Kanae Suzuki, Koichi Nakamura, Yumi Nishiya, Takahiko Seki, Masato Itoh, Ayuna Hattori, Takuo Katsumoto, Kazutsune Yamagata, Yutaka Shima, Yoko Ogawara, Masayuki Yamaguchi, Hironori Matsunaga, Makoto Nakagawa, Yukino Machida
Gliomas are the second most common primary brain tumors in adults. They are treated with combination therapies, including surgery, radiotherapy, and chemotherapy. There are currently limited treatment options for recurrent gliomas, and new targeted t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e1a0a6bd08d3d1c33b1bb99880b6be
https://doi.org/10.1158/1535-7163.c.6539320
https://doi.org/10.1158/1535-7163.c.6539320
Autor:
Michiko Yamato, Jun Hasegawa, Takanori Maejima, Chiharu Hattori, Kazuyoshi Kumagai, Akiko Watanabe, Yumi Nishiya, Tomoko Shibutani, Tetsuo Aida, Ichiro Hayakawa, Takashi Nakada, Yuki Abe, Toshinori Agatsuma
Publikováno v:
Molecular Cancer Therapeutics. 21:635-646
B7-H3 is overexpressed in various solid tumors and has been considered as an attractive target for cancer therapy. Here, we report the development of DS-7300a, a novel B7-H3–targeting antibody–drug conjugate with a potent DNA topoisomerase I inhi
Publikováno v:
Xenobiotica. 52:54-64